SLC25A20 and metabolic disease: The acylcarnitine profile displays a characteristic alteration in inherited metabolic diseases, such as short chain and medium chain acyl coenzyme A dehydrogenase deficiency, and carnitine acylcarnitine translocase deficiency (18).